Skip to content

Neoadjuvant Database

Prospective and Retrospective Neoadjuvant Breast Cancer Database

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04031612
Acronym
NEOADJ
Enrollment
2000
Registered
2019-07-24
Start date
2009-09-09
Completion date
2024-09-30
Last updated
2019-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoadjuvant Treatment in Breast Cancer

Keywords

Cancer; Breast, Neoadjuvant

Brief summary

The NEOADJ Database base contains data collected during the regular clinical patient management (sociodemographic, clinical, pathological, radiological, biological, disease evolution...). This database allows easy access to information in a centralized and structured way. This cohort is used to gather insights for research purposes. All data collected come from medical files of patients managed at Centre Georges Francois Leclerc, Dijon, France.

Interventions

DRUGNeoadjuvant therapy

Neoadjuvant therapy

Sponsors

Centre Georges Francois Leclerc
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women followed for breast cancer in Georges Francois Leclerc Center * Neoadjuvant chemotherapy * Age \>= 18

Exclusion criteria

* Males * Metastatic breast cancer

Design outcomes

Primary

MeasureTime frameDescription
Patient survival5 yearsOverall survival and evolution over years

Secondary

MeasureTime frameDescription
Collection of patient and treatment characteristics5 yearsCollection of patient and treatment characteristics over years, to set up prospective and retrospective studies

Countries

France

Contacts

Primary ContactAURELIE BERTAUT, MD, PHD
ABertaut@cgfl.fr+33 3 80 73 77 84

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026